Tim Warren

2 POSTS 0 COMMENTS

Latest articles

NICE to work with GW Pharma on cannabidiol evaluation

NICE to work with GW Pharma on cannabidiol evaluation

NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...
NHS Spine marks five years of being run as an open source service

NHS Spine marks five-year anniversary

NHS Spine is marking five years since it was brought in house by NHS Digital and run as an open source service for the...
robot holding chess piece: Cyber threats in healthcare

Cyber threats in healthcare: What are the risks?

FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Cannuba supports 20,000-strong pilot study on medical cannabis

UK’s first national medical cannabis pilot study launched

CBD and full spectrum cannabis oil brand, Cannuba, is supporting the UK’s first national pilot study for medical cannabis, Project TWENTY21, which launched earlier...
Roche's Hemlibra® available on NHS

NHS England makes Roche’s Hemlibra® available on NHS

NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
Positive results for long acting injectable HIV treatment regimen

Positive phase III study results for injectable HIV-treatment regimen

ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...

Pancreatic Cancer Story: John William Street

Pancreatic cancer is the 10th most common cancer in the UK, with around 9600 people diagnosed each year. The disease has the lowest survival...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription